Acorda Therapeutics Inc. (NASDAQ: ACOR) Enters Supply and Distribution Agreement for INBROJA with Esteve Pharmaceuticals

July 26, 2021

Acorda Therapeutics Inc. (NASDAQ: ACOR) jumped 24.15% after the company announced the signing of supply and distribution agreements for INBRIJA commercialization in Spain. ESTEVE to distribute INBRIJA in Spain  The company and Esteve Pharmaceuticals S.A entered the commercialization deal to distribute levodopa inhalation powder, INBRIJA, in the country. Currently, levodopa is indicated in the European Union for intermittent episodic motor fluctuations (OFF episodes) in Parkinson’s disease patients treated with levodopa…

Read More >>